Difficult-to-Diagnose Hormone-Negative, Human Epidermal Growth Factor Receptor 2-Positive Poorly-Differentiated Breast Cancer in a Male Patient

Annals of Breast Cancer and Therapy(2020)

Cited 0|Views5
No score
Abstract
Male breast cancer is rare, accounting for approximately 0.5-1.0% of all cases and is often a hormone-dependent luminal type. The percentage of hormone-negative, human epidermal growth factor receptor 2 (HER2)-positive breast cancer cases is very small in male patients (0.6-1.2%), and the prognosis is generally poor.
More
Translated text
Key words
breast cancer,difficult-to-diagnose,hormone-negative,poorly-differentiated
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined